Novo Nordisk A/S (ETR:NOV)
Germany · Delayed Price · Currency is EUR 49.88
-0.32 (-0.64%)
Feb 2, 2026, 5:49 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of €219.87 billion as of February 2, 2026. Its market cap has decreased by -37.58% in one year.
Market Cap
219.87B
Enterprise Value
229.06B
Revenue
42.26B
Ranking
n/a
PE Ratio
15.82
Stock Price
€49.88
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 6.23B to 219.87B, an increase of 3,431.03%. That is a compound annual growth rate of 13.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 219.87B | 13.62% |
| Dec 30, 2025 | 193.51B | -47.96% |
| Dec 30, 2024 | 371.85B | -10.95% |
| Dec 29, 2023 | 417.56B | 46.59% |
| Dec 30, 2022 | 284.85B | 26.44% |
| Dec 30, 2021 | 225.29B | 69.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| Sartorius Aktiengesellschaft | 14.69B |
| Fresenius Medical Care AG | 10.52B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |